ArticlePharmacogenomics2011

Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.

Maria J Lamas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.